GlassScriptPhysician profile
Edward A Pankey
NPI 1285020537
$885.94
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $36.56 · 2021: $123 · 2022: $61.99 · 2023: $350 · 2024: $82.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.20 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $356.40 | 2019-2024 | |
| Nevro Corp. | $266.63 | 2019-2023 | Senza |
| Medtronic, INC. | $122.73 | 2021 | |
| Flowonix Medical Incorporated | $43.21 | 2019-2020 | |
| Abbott Laboratories | $38.37 | 2022-2023 | Freestyle Libre 2 |
| Dynavax Technologies Corporation | $17.12 | 2022 | |
| Tersera Therapeutics LLC | $15.75 | 2020 | |
| Lilly USA, LLC | $13.93 | 2022 | |
| Glaxosmithkline, LLC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Pankey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.